Effect of Wnt5a on aggressiveness of estrogen receptor-positive breast cancer and cancer cell migration through ALCAM pathway

被引：0
|
作者：
Kobayashi, Yoshie [1 ]
Kadoya, Takayuki [1 ]
Amioka, Ai [1 ]
Hanaki, Hideaki [1 ]
Sasada, Shinsuke [1 ]
Masumoto, Norio [1 ]
Arihiro, Koji [2 ]
Kikuchi, Akira [3 ]
Okada, Morihito [1 ]
机构：
[1] Hiroshima Univ, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Hiroshima, Japan
[3] Osaka Univ, Osaka, Japan
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-30
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
30
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effect of Wnt5a on aggressiveness of ER-positive breast cancer and cancer cell migration through JNK-ALCAM pathway.
    Kobayashi, Yoshie
    Kadoya, Takayuki
    Amioka, Ai
    Gohda, Noriko
    Kano, Miho
    Sasada, Shinsuke
    Kajitani, Keiko
    Masumoto, Norio
    Okada, Morihito
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
    Amioka, Ai
    Kadoya, Takayuki
    Sueoka, Satoshi
    Kobayashi, Yoshie
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Ito, Masaoki
    Okada, Morihito
    CANCER RESEARCH, 2021, 81 (04)
  • [3] Wnt5a Is a Prognostic Biomarker in Estrogen Receptor-Positive Premenopausal Breast Cancer.
    Sand-Dejmek, J. T.
    Ehrnstrom, R.
    Andersson, T.
    Ryden, L.
    CANCER RESEARCH, 2011, 71
  • [4] Correction to: Effect of Wnt5a on drug resistance in estrogen receptor‑positive breast cancer
    Ai Amioka
    Takayuki Kadoya
    Satoshi Sueoka
    Yoshie Kobayashi
    Shinsuke Sasada
    Akiko Emi
    Norio Masumoto
    Masaoki Ito
    Koh Nakayama
    Morihito Okada
    Breast Cancer, 2021, 28 : 1072 - 1072
  • [5] Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer (June, 10.1007/s12282-021-01241-0, 2021)
    Amioka, Ai
    Kadoya, Takayuki
    Sueoka, Satoshi
    Kobayashi, Yoshie
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Ito, Masaoki
    Nakayama, Koh
    Okada, Morihito
    BREAST CANCER, 2021, 28 (05) : 1072 - 1072
  • [6] Treatment of Estrogen Receptor-Positive Breast Cancer
    Lumachi, F.
    Brunello, A.
    Maruzzo, M.
    Basso, U.
    Basso, S. M. M.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (05) : 596 - 604
  • [7] The role of stat5 in estrogen receptor-positive breast cancer
    Hiroko Yamashita
    Hirotaka Iwase
    Breast Cancer, 2002, 9 (4) : 312 - 318
  • [8] Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer
    Agrawal, Anil
    Ziolkowski, Piotr
    Grzebieniak, Zygmunt
    Jelen, Michal
    Bobinski, Piotr
    Agrawal, Siddarth
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (08) : 550 - 555
  • [9] New Strategies in Estrogen Receptor-Positive Breast Cancer
    Johnston, Stephen R. D.
    CLINICAL CANCER RESEARCH, 2010, 16 (07) : 1979 - 1987
  • [10] Geographic excess of estrogen receptor-positive breast cancer
    Benz, CC
    Clarke, CA
    Moore, DH
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (12) : 1523 - 1527
12345